language_icon
EN
HI

Kilitch Drugs (India) Share price

KILITCH

133.19

5.46 (-3.94%)
NSE
BSE
Last updated on 6 Apr, 2026 | 15:58 IST
Today's High

142.61

Today's Low

132.66

52 Week Low

117.25

52 Week High

250.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Kilitch Drugs (India) Chart

Kilitch Drugs (India) Share Key Metrics

Volume
93416.00
Market Cap
465.65 CR
LTQ@LTP
5@133.19
ATP
135.88
Var Margin
20.6 %
Circuit Range
110.92-166.38
Delivery %
55.2 %
Value
1.27 CR
ASM/GSM
No
Market Lot
1

Summary

At 6 Apr, 2026 | 15:58, Kilitch Drugs (India) share price stands at ₹133.19, showing a 5.46% -3.94 for the day. The stock’s intraday movement has stayed between ₹132.66 and ₹142.61, while on a 52-week basis it has fluctuated from ₹117.25 to ₹250.00.
In terms of trading activity, Kilitch Drugs (India) has recorded a volume of 93416 shares, with a market capitalisation of ₹34961564. The stock’s Average Traded Price (ATP) stands at ₹13588, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5,13319. The stock operates within a circuit range of ₹110.92-166.38, with a Value of ₹1.27 CR. The Delivery Percentage for the day is 55.2%. Additionally, Kilitch Drugs (India) currently falls under the No framework, and trades with a market lot size of 1.

Kilitch Drugs (India) Fundamentals

View More
P/E Ratio

18.65

P/B Ratio

1.69

Div. Yield

0

Sector P/E

60.59

Sector P/B

3.25

Sec. Div. Yield

0.59

Kilitch Drugs (India) Resistance and Support

Pivot 136.93

Resistance

First Resistance

141.66

Second Resistance

144.67

Third Resistance

149.4

Support

First Support

133.92

Second Support

129.19

Third Support

126.18

Kilitch Drugs (India) Futures & Options

Data Not Found

Kilitch Drugs (India) Shareholding Pattern

View More
  • 2021-22
  • 2024-25
  • 2023-24
  • 2022-23
  • 2020-21
  • 2016-17
  • 2025-26
  • 2019-20
  • 2018-19
Total Promoters
Segment
Percent

Total Promoters

69.25%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0.04%

Retail

30.71%

Others

0%

Total Promoters
MAR '18
65.79%
JUN '18
65.79%
SEP '18
69.25%
DEC '18
69.25%

Kilitch Drugs (India) Corporate Actions

DateAgenda
2026-02-11Quarterly Results & Bonus issue
2025-11-13Quarterly Results
2025-05-19Audited Results
2025-02-11Quarterly Results

Kilitch Drugs (India) News

Kilitch Drugs India Ltd - 524500 - Board Meeting Outcome for Allotment Of Bonus Equity Shares

Kilitch Drugs board approved a 1:1 bonus issue, allotting 1,74,80,782 equity shares of ₹10 each. The bonus shares will rank pari-passu with existing fully paid-up equity shares. Record date for bonus entitlement is March 24, 2026.
Mar 25 2026 12:03:00

Kilitch Drugs (India) Limited

Kilitch Drugs (India) Ltd. has fixed March 24, 2026, as the record date for its 1:1 bonus equity share issue. Shareholders will receive one bonus share of ₹10 each for every share held, with the deemed allotment date set for March 25, 2026.
Mar 17 2026 15:03:00
Read More

About Kilitch Drugs (India)

NSE : 19937  
BSE : 524500  
ISIN : INE729D01010  

M/s Kilitch Drugs (India) ltd was incorporated on 12th May 1992 with the Registrar of Companies Maharashtra at Bombay as a public limited company and obtained certificate for commencement of business dated 26-05-92. The company went Public in February 1994 for setting up a pharmaceutical formulation plant to manufacture pharmaceutical products in the form of tablets capsules liquid orals ointments creams and injectables. The company could not commence its manufacturing activities as planned in the Public Issue on account of delay in completion of building. Till date the company has not commenced any manufacturing activities. The land and building is now completed and in order to have the benefit of its capacity the company is planning thisrights issue for expanding its injectable capacity from 30000 ltrs. to 75000 Itrs.PRESENT BUSINESSDue to delay in implementation of project the company could not come out with its own production till date and therefore the company is presently trading in pharmaceutical formulations like tablets capsules liquid orals ointments creams and injectables. The tradingturnover of the company for the year 1994-95 was Rs.550.50 Lacs.

Read More

Kilitch Drugs (India) Management

NamePosition
Mr. Mukund P Mehta Managing Director
Mr. Bhavin Mukund Mehta Whole Time Director
View More

Kilitch Drugs (India) FAQs

The Buying Price of Kilitch Drugs (India) share is 133.19 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Kilitch Drugs (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kilitch Drugs (India), choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Kilitch Drugs (India) shares is 18.65. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Kilitch Drugs (India) shares is 1.69. Useful to assess the stock's value relative to its book value.

To assess Kilitch Drugs (India)’s valuation compare Sector P/E, P/B which are 60.59 & 3.25 with sector averages, along with growth rates and financial metrics.

The Market Cap of Kilitch Drugs (India) is 465.65 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Kilitch Drugs (India) share price is 250.00 & 117.25. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Kilitch Drugs (India) belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost